GRI BIO INC

Gri Bio’s latest filing shows strong sustainability gains, solar expansion, and low operating costs—boosting ESG appeal and potential investor confidence.

Gri Bio (GRI) shares climb 0.68% to $1.47, trading 86.7k USD. Explore its clinical‑stage biotech focus on NKT immune cell therapies and market snapshot.